The manuscript mentions Brca1 S988 as a Chk2 substrate important for DSB repair ... We apologize for this labeling error, which has now been corrected. (5) For the 53BP1 MFI and Rad51 MFI shown in Fig ...

As we count down the last few days on the calendar, the time has come to reflect back on a newsworthy year in the Klamath Basin, with some stories making national and even international headlines.

The multicenter OlympiA trial enrolled 1836 patients with HER2-negative breast cancer harboring a germline BRCA1/2 mutation. Patients were randomized 1:1 to receive 300 mg of oral olaparib twice daily ...

We are pleased to introduce the EMBO reports Advisory Editorial Board. Members of the Board provide scientific advice to the editors for which we are very grateful. Should you wish to contact a Board ...